Health System Pharmacy Legislation: Key Trends
- The expanding scope of pharmacist practice is creating new opportunities, but looming federal policy changes present significant financial challenges for health systems.
- Kraus noted that state-level legislation is driving much of the positive change.This year alone, 20 states have passed bills expanding what pharmacists can do, with some incorporating standard...
- However, federal actions related to drug pricing and reimbursement threaten to undermine these gains.
Health system pharmacy legislation is at a crossroads: Pharmacists’ roles are expanding due to state laws,yet federal policies on drug pricing and hospital reimbursement pose major hurdles.Tom Kraus, VP of Government Relations, details these key trends, revealing that while 20 states have broadened pharmacists’ scope, potential federal actions could slash reimbursements for 340B entities. Moreover, site-neutral payment proposals threaten hospital funding, potentially impacting patient care. Stay informed of the latest policy shifts with News Directory 3. Discover what’s next for health systems and pharmacies as they navigate this complex landscape.
Pharmacist Scope Expansion Faces Drug Pricing Challenges
Updated June 10, 2025
The expanding scope of pharmacist practice is creating new opportunities, but looming federal policy changes present significant financial challenges for health systems. Tom Kraus, Vice President of Government Relations, addressed these issues at the American Society of Health-System Pharmacists (ASHP) 2025 Pharmacy Futures meeting, highlighting both the promise and peril facing the profession.
Kraus noted that state-level legislation is driving much of the positive change.This year alone, 20 states have passed bills expanding what pharmacists can do, with some incorporating standard of care models. This pharmacist role evolution is seen as a major step forward.
However, federal actions related to drug pricing and reimbursement threaten to undermine these gains. Kraus pointed to a presidential executive order directing agencies to examine acquisition costs for 340B-covered entities. While the order doesn’t explicitly call for reimbursement cuts, Kraus warned that it sets the stage for Medicare to reduce payments to these entities in the future.
Another concern is the potential for site-neutral payment policies. As Congress seeks ways to fund legislative packages, it may turn to these policies, which would reduce hospital reimbursement for procedures, imaging, and even drug administration. Kraus cautioned that while this would save the government money, it would substantially impact health system finances.
What’s next
Health systems and pharmacists will need to closely monitor both state and federal policy changes to navigate the evolving landscape and advocate for policies that support patient care and financial stability.